Cite
MLA Citation
Alison Findlay et al.. “An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies.” Clinical and translational medicine, vol. 11, no. 11, 2021, p. n/a. http://access.bl.uk/ark:/81055/vdc_100169752966.0x000010